Consider GLP-1 receptor agonists like semaglutide or liraglutide. These medications offer a different mechanism of action, potentially improving blood sugar control and weight management. They’re administered via injection, a factor to discuss with your doctor.
Another viable option includes SGLT2 inhibitors, such as dapagliflozin or empagliflozin. These drugs work by increasing glucose excretion in the urine. Studies show they effectively lower blood sugar and can reduce cardiovascular risk, making them particularly suitable for patients with existing heart conditions. Remember to discuss potential side effects, such as increased urination, with your physician.
DPP-4 inhibitors, such as sitagliptin or saxagliptin, represent a third category of alternatives. These medications enhance the body’s natural insulin production. They are often well-tolerated, but efficacy varies among individuals. A thorough discussion with your healthcare provider is necessary to determine suitability.
Important Note: This information is for educational purposes only and does not constitute medical advice. Always consult your doctor before making changes to your medication regimen. Your doctor will consider your individual medical history, other health conditions, and preferences to determine the most appropriate treatment plan.
